Ozone-Therapy-Immunoglobulin A deficiency-adults and childrens-Phase II
Phase 2
- Conditions
- Immunoglobulin A DeficiencyIgA DeficiencyDysgammaglobulinemiaBlood Protein DisordersHemic Diseases Hemic and Lymphatic DiseasesImmunologic Deficiency SyndromesImmune System Diseases
- Registration Number
- RPCEC00000236
- Lead Sponsor
- Roberto Rodriguez Fernandez General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1- IgA deficiency complete or partial, selective IgA deficiency or with deficient specific antibody response, IgAD isolated or associated to allergic , autoimmune and neoplasic illness.
2- Informed Consent of the parents for the participation of childrens in the study or Signed informed consent of the adults .
Exclusion Criteria
1- Having received blood transfusions three previous months or during the study
2- Having recived immunomodulator treatment 6 previous months to study.
3- Any specific conditions that advise against any one of the treatments.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method